Cold-adapted enzymes could change the future of medicine

With applications in biomedicine, biomaterials and advanced biomanufacturing

Ned and Hamid wearing lab coats and smiling at the camera.
Estimated Read Time:
1 minute
Dr. Ned Budisa and Dr. Hamidreza Karbalaeiheidari
Dr. Ned Budisa and Dr. Hamidreza Karbalaeiheidari
Estimated Read Time:
1 minute
By

Kimia Shadkami

What if the answer to improving the quality of life and combating neurodegenerative diseases could also help answer one of humanity’s oldest questions: what is the origin of life? The connection lies in the evolutionary field of protein editing in biotechnology.

Dr. Ned Budisa, a professor and (Tier 1) Canada Research Chair in chemical synthetic biology at the University of Manitoba, is taking a closer look at protein editing and is exploring more efficient approaches. According to Budisa, if we can understand the chemical origin of the transformation of one protein with normal physiological functions into one with pathological functions, we can replace that one building block and prevent harm to our health.

Hamid pipetting while talking to Ned.
Dr. Ned Budisa and Dr. Hamidreza Karbalaeiheidari

A novel approach to protein editing

The problem is the lack of efficient systems. Currently, the field relies on heat-loving translation enzymes (synthetases) to build engineered proteins. These enzymes are extremely rigid, and evolving them to recognize and load alternative chemical building blocks is a massive hurdle. This makes the entire process expensive, inefficient and hard to scale.

Budisa and his research group, including Dr. Hamidreza Karbalaeiheidari, a visiting professor at the Department of Chemistry, have developed a novel approach to protein editing.

The key is cold-adapted enzymes. The researchers’ new approach explores biology adapted to extreme cold, reducing the cost and making the process more energy-efficient and sustainable.

Ned and Hamid discussing and writing on a white board.
Dr. Ned Budisa and Dr. Hamidreza Karbalaeiheidari
Supported by NSERC and the Canada Research Chairs Program, this work helps position Canada at the forefront of sustainable synthetic biology and highlights the potential of cold and Arctic environments as sources of industrially valuable enzymes.

Dr. Ned Budisa, Professor, (Tier 1) Canada Research Chair in Chemical Synthetic Biology

Ned wearing a blue button down shirt smiling at the camera.
Dr. Ned Budisa, Professor, (Tier 1) Canada Research Chair in Chemical Synthetic Biology

Reimagining the future

The vision for the future is scaling the platform to produce increasingly complex designer proteins. This could have applications in biomedicine, biomaterials and advanced biomanufacturing.

To learn more about Budisa and his team's research, please watch the following video on the Faculty of Science's YouTube channel.

Boilerplate: Creating knowledge

UM is home to researchers and scholars who respond to emerging issues and lead innovation in our province and around the world. Creating knowledge that matters is one of the strategic themes you’ll find in MomentUM: Leading change together the University of Manitoba’s 2024–2029 strategic plan.